Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 2Phase 2 1Phase 1 1

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 3Plasma cell 2Other hematologic neoplasm 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Hematologic Neoplasms 272Leukemia, Myeloid, Acute 255Leukemia 234Lymphoma 127Leukemia, Lymphocytic, Chronic, B-Cell 110Multiple Myeloma 108Neoplasms 95Myelodysplastic Syndromes 95Lymphoma, Non-Hodgkin 94Hodgkin Disease 76Burkitt Lymphoma 64Lymphoma, Mantle-Cell 61Lymphoma, Follicular 60Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Lymphoma, Large B-Cell, Diffuse 56Myeloproliferative Disorders 54Lymphoma, B-Cell, Marginal Zone 53Lymphoma, Large-Cell, Immunoblastic 47Congenital Abnormalities 47Motor Activity 45Leukemia, Myeloid, Chronic-Phase 45Primary Myelofibrosis 43Lymphoma, T-Cell, Cutaneous 43Recurrence 41Sezary Syndrome 39Mycosis Fungoides 39Leukemia, Myeloid, Accelerated Phase 38Neoplasms, Plasma Cell 35Breast Neoplasms 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Cytokine Release Syndrome × Other hematologic neoplasm × Clear all
NCT07499128 2026-06-01

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

National Institutes of Health Clinical Center (CC)

Phase NA Enrolling by invitation
136 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cytokine Release Syndrome, Lymphoma, Multiple Myeloma, Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06377059 2026-05-15

Early Detection of Complications During Immunotherapy for Haematological Malignancy

Rigshospitalet, Denmark

Phase NA Recruiting
100 enrolled
Other hematologic neoplasm

Cytokine Release Syndrome, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡